Copyright Reports & Markets. All rights reserved.

Global Non-GLP Acute Toxicology Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Non-GLP Acute Toxicology Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Acute Toxicity Testing
    • 1.2.3 In vitro Cytotoxicity Testing
    • 1.2.4 Genotoxicity Testing
  • 1.3 Market by Application
    • 1.3.1 Global Non-GLP Acute Toxicology Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Rodents
    • 1.3.3 Canine
    • 1.3.4 Rabbit
    • 1.3.5 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Non-GLP Acute Toxicology Market Perspective (2016-2027)
  • 2.2 Non-GLP Acute Toxicology Growth Trends by Regions
    • 2.2.1 Non-GLP Acute Toxicology Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Non-GLP Acute Toxicology Historic Market Share by Regions (2016-2021)
    • 2.2.3 Non-GLP Acute Toxicology Forecasted Market Size by Regions (2022-2027)
  • 2.3 Non-GLP Acute Toxicology Industry Dynamic
    • 2.3.1 Non-GLP Acute Toxicology Market Trends
    • 2.3.2 Non-GLP Acute Toxicology Market Drivers
    • 2.3.3 Non-GLP Acute Toxicology Market Challenges
    • 2.3.4 Non-GLP Acute Toxicology Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Non-GLP Acute Toxicology Players by Revenue
    • 3.1.1 Global Top Non-GLP Acute Toxicology Players by Revenue (2016-2021)
    • 3.1.2 Global Non-GLP Acute Toxicology Revenue Market Share by Players (2016-2021)
  • 3.2 Global Non-GLP Acute Toxicology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Non-GLP Acute Toxicology Revenue
  • 3.4 Global Non-GLP Acute Toxicology Market Concentration Ratio
    • 3.4.1 Global Non-GLP Acute Toxicology Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Non-GLP Acute Toxicology Revenue in 2020
  • 3.5 Non-GLP Acute Toxicology Key Players Head office and Area Served
  • 3.6 Key Players Non-GLP Acute Toxicology Product Solution and Service
  • 3.7 Date of Enter into Non-GLP Acute Toxicology Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Non-GLP Acute Toxicology Breakdown Data by Type

  • 4.1 Global Non-GLP Acute Toxicology Historic Market Size by Type (2016-2021)
  • 4.2 Global Non-GLP Acute Toxicology Forecasted Market Size by Type (2022-2027)

5 Non-GLP Acute Toxicology Breakdown Data by Application

  • 5.1 Global Non-GLP Acute Toxicology Historic Market Size by Application (2016-2021)
  • 5.2 Global Non-GLP Acute Toxicology Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Non-GLP Acute Toxicology Market Size (2016-2027)
  • 6.2 North America Non-GLP Acute Toxicology Market Size by Type
    • 6.2.1 North America Non-GLP Acute Toxicology Market Size by Type (2016-2021)
    • 6.2.2 North America Non-GLP Acute Toxicology Market Size by Type (2022-2027)
    • 6.2.3 North America Non-GLP Acute Toxicology Market Size by Type (2016-2027)
  • 6.3 North America Non-GLP Acute Toxicology Market Size by Application
    • 6.3.1 North America Non-GLP Acute Toxicology Market Size by Application (2016-2021)
    • 6.3.2 North America Non-GLP Acute Toxicology Market Size by Application (2022-2027)
    • 6.3.3 North America Non-GLP Acute Toxicology Market Size by Application (2016-2027)
  • 6.4 North America Non-GLP Acute Toxicology Market Size by Country
    • 6.4.1 North America Non-GLP Acute Toxicology Market Size by Country (2016-2021)
    • 6.4.2 North America Non-GLP Acute Toxicology Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.3 Canada

7 Europe

  • 7.1 Europe Non-GLP Acute Toxicology Market Size (2016-2027)
  • 7.2 Europe Non-GLP Acute Toxicology Market Size by Type
    • 7.2.1 Europe Non-GLP Acute Toxicology Market Size by Type (2016-2021)
    • 7.2.2 Europe Non-GLP Acute Toxicology Market Size by Type (2022-2027)
    • 7.2.3 Europe Non-GLP Acute Toxicology Market Size by Type (2016-2027)
  • 7.3 Europe Non-GLP Acute Toxicology Market Size by Application
    • 7.3.1 Europe Non-GLP Acute Toxicology Market Size by Application (2016-2021)
    • 7.3.2 Europe Non-GLP Acute Toxicology Market Size by Application (2022-2027)
    • 7.3.3 Europe Non-GLP Acute Toxicology Market Size by Application (2016-2027)
  • 7.4 Europe Non-GLP Acute Toxicology Market Size by Country
    • 7.4.1 Europe Non-GLP Acute Toxicology Market Size by Country (2016-2021)
    • 7.4.2 Europe Non-GLP Acute Toxicology Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Non-GLP Acute Toxicology Market Size (2016-2027)
  • 8.2 Asia-Pacific Non-GLP Acute Toxicology Market Size by Type
    • 8.2.1 Asia-Pacific Non-GLP Acute Toxicology Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Non-GLP Acute Toxicology Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Non-GLP Acute Toxicology Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Non-GLP Acute Toxicology Market Size by Application
    • 8.3.1 Asia-Pacific Non-GLP Acute Toxicology Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Non-GLP Acute Toxicology Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Non-GLP Acute Toxicology Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Non-GLP Acute Toxicology Market Size by Region
    • 8.4.1 Asia-Pacific Non-GLP Acute Toxicology Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Non-GLP Acute Toxicology Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Non-GLP Acute Toxicology Market Size (2016-2027)
  • 9.2 Latin America Non-GLP Acute Toxicology Market Size by Type
    • 9.2.1 Latin America Non-GLP Acute Toxicology Market Size by Type (2016-2021)
    • 9.2.2 Latin America Non-GLP Acute Toxicology Market Size by Type (2022-2027)
    • 9.2.3 Latin America Non-GLP Acute Toxicology Market Size by Type (2016-2027)
  • 9.3 Latin America Non-GLP Acute Toxicology Market Size by Application
    • 9.3.1 Latin America Non-GLP Acute Toxicology Market Size by Application (2016-2021)
    • 9.3.2 Latin America Non-GLP Acute Toxicology Market Size by Application (2022-2027)
    • 9.3.3 Latin America Non-GLP Acute Toxicology Market Size by Application (2016-2027)
  • 9.4 Latin America Non-GLP Acute Toxicology Market Size by Country
    • 9.4.1 Latin America Non-GLP Acute Toxicology Market Size by Country (2016-2021)
    • 9.4.2 Latin America Non-GLP Acute Toxicology Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Non-GLP Acute Toxicology Market Size (2016-2027)
  • 10.2 Middle East & Africa Non-GLP Acute Toxicology Market Size by Type
    • 10.2.1 Middle East & Africa Non-GLP Acute Toxicology Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Non-GLP Acute Toxicology Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Non-GLP Acute Toxicology Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Non-GLP Acute Toxicology Market Size by Application
    • 10.3.1 Middle East & Africa Non-GLP Acute Toxicology Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Non-GLP Acute Toxicology Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Non-GLP Acute Toxicology Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Non-GLP Acute Toxicology Market Size by Country
    • 10.4.1 Middle East & Africa Non-GLP Acute Toxicology Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Non-GLP Acute Toxicology Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 HSRL
    • 11.1.1 HSRL Company Details
    • 11.1.2 HSRL Business Overview
    • 11.1.3 HSRL Non-GLP Acute Toxicology Introduction
    • 11.1.4 HSRL Revenue in Non-GLP Acute Toxicology Business (2016-2021)
    • 11.1.5 HSRL Recent Development
  • 11.2 Charles River
    • 11.2.1 Charles River Company Details
    • 11.2.2 Charles River Business Overview
    • 11.2.3 Charles River Non-GLP Acute Toxicology Introduction
    • 11.2.4 Charles River Revenue in Non-GLP Acute Toxicology Business (2016-2021)
    • 11.2.5 Charles River Recent Development
  • 11.3 IITRI
    • 11.3.1 IITRI Company Details
    • 11.3.2 IITRI Business Overview
    • 11.3.3 IITRI Non-GLP Acute Toxicology Introduction
    • 11.3.4 IITRI Revenue in Non-GLP Acute Toxicology Business (2016-2021)
    • 11.3.5 IITRI Recent Development
  • 11.4 CARE Research
    • 11.4.1 CARE Research Company Details
    • 11.4.2 CARE Research Business Overview
    • 11.4.3 CARE Research Non-GLP Acute Toxicology Introduction
    • 11.4.4 CARE Research Revenue in Non-GLP Acute Toxicology Business (2016-2021)
    • 11.4.5 CARE Research Recent Development
  • 11.5 MediTox sro
    • 11.5.1 MediTox sro Company Details
    • 11.5.2 MediTox sro Business Overview
    • 11.5.3 MediTox sro Non-GLP Acute Toxicology Introduction
    • 11.5.4 MediTox sro Revenue in Non-GLP Acute Toxicology Business (2016-2021)
    • 11.5.5 MediTox sro Recent Development
  • 11.6 VivoPharm
    • 11.6.1 VivoPharm Company Details
    • 11.6.2 VivoPharm Business Overview
    • 11.6.3 VivoPharm Non-GLP Acute Toxicology Introduction
    • 11.6.4 VivoPharm Revenue in Non-GLP Acute Toxicology Business (2016-2021)
    • 11.6.5 VivoPharm Recent Development
  • 11.7 Celerion
    • 11.7.1 Celerion Company Details
    • 11.7.2 Celerion Business Overview
    • 11.7.3 Celerion Non-GLP Acute Toxicology Introduction
    • 11.7.4 Celerion Revenue in Non-GLP Acute Toxicology Business (2016-2021)
    • 11.7.5 Celerion Recent Development
  • 11.8 Bienta
    • 11.8.1 Bienta Company Details
    • 11.8.2 Bienta Business Overview
    • 11.8.3 Bienta Non-GLP Acute Toxicology Introduction
    • 11.8.4 Bienta Revenue in Non-GLP Acute Toxicology Business (2016-2021)
    • 11.8.5 Bienta Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Non-GLP Acute Toxicology market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Non-GLP Acute Toxicology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Acute Toxicity Testing
    In vitro Cytotoxicity Testing
    Genotoxicity Testing

    Segment by Application
    Rodents
    Canine
    Rabbit
    Others

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    HSRL
    Charles River
    IITRI
    CARE Research
    MediTox sro
    VivoPharm
    Celerion
    Bienta
    CARE Research

    Buy now